Fusion Transcript Detection

  • Fusion transcript detection is a bioinformatics approach used to identify RNA molecules formed when sequences from two different genes become joined within a single transcript. These molecules are known as fusion transcripts and may result from chromosomal rearrangements, gene fusions, alternative transcription, read-through transcription, or other molecular mechanisms. Fusion transcripts can contain coding and regulatory sequences from different genes, potentially producing abnormal proteins or changing normal gene expression. Their detection is particularly important in cancer research, molecular diagnostics, functional genomics, and transcriptome analysis.
  • A gene fusion occurs when two previously separate genes or portions of genes become physically or transcriptionally connected. In many cases, gene fusions result from structural chromosomal alterations such as translocations, inversions, deletions, or duplications. These rearrangements can bring coding regions from different genes together, producing a hybrid gene that is transcribed into a fusion RNA molecule. For example, a chromosomal translocation may connect the regulatory region of one gene with the coding sequence of another, resulting in abnormal expression or a fusion protein with altered biological activity.
  • Fusion transcripts can also arise without a detectable chromosomal rearrangement. Read-through transcription occurs when RNA polymerase continues transcription beyond the normal termination region of one gene into a neighboring gene, producing a continuous RNA molecule containing sequences from both genes. Trans-splicing can join RNA molecules transcribed from separate genomic regions, although its biological occurrence and importance vary among organisms and tissues. Other mechanisms, including complex structural variants and alternative RNA processing, may also contribute to fusion transcript formation. Therefore, detecting a fusion transcript does not automatically establish that a genomic rearrangement has occurred.
  • Fusion transcripts can produce several biological outcomes. Some generate fusion proteins containing functional domains from both original proteins, potentially creating new enzymatic activities, altered protein interactions, or abnormal cellular signaling. Other fusion transcripts may encode truncated proteins, remove regulatory regions, or introduce premature termination codons. Certain fusion RNAs may not produce functional proteins but can still influence gene expression or RNA regulation. The biological effect depends on the fusion partners, breakpoint positions, reading frame, transcript structure, expression level, and cellular context.
  • RNA sequencing (RNA-seq) is widely used for fusion transcript detection because it identifies RNA molecules containing sequences from different genes. During RNA-seq analysis, sequencing reads are aligned to a reference genome or transcriptome. Reads containing portions of two different genes may indicate a fusion transcript. Two important types of evidence are split reads and spanning reads. Split reads contain sequences mapping to different genes or genomic regions within a single sequencing read, directly supporting a fusion breakpoint. Spanning reads, also called discordant read pairs, consist of paired-end reads mapping to different genes or regions in an unexpected orientation or distance. These reads provide supporting evidence that two genomic regions may be connected within the same RNA molecule.
  • A typical fusion transcript detection workflow begins with RNA extraction and quality assessment. RNA integrity is particularly important because degraded RNA can reduce fusion transcript detection and affect breakpoint identification. RNA sequencing libraries may be prepared using poly(A) selection or ribosomal RNA depletion, depending on the research objective. Poly(A) selection enriches mature polyadenylated transcripts, while ribosomal RNA depletion can retain a broader range of RNA molecules. Sequencing depth, read length, paired-end sequencing, and library preparation methods influence the ability to detect fusion transcripts, especially those expressed at low levels.
  • After sequencing, raw reads are assessed using FastQC and MultiQC. Adapter contamination and low-quality bases may be removed using Cutadapt or fastp. Clean reads are then analyzed using specialized fusion detection algorithms. Some tools perform fusion-aware alignment, while others examine discordant read pairs, split reads, or transcript assembly evidence. Fusion candidates are subsequently filtered and evaluated using supporting read counts, breakpoint consistency, gene annotation, expression levels, and biological information.
  • Several computational tools are commonly used for fusion transcript detection. STAR-Fusion uses chimeric alignment information generated by the STAR aligner to identify candidate fusion transcripts. Arriba is designed for fusion detection from RNA-seq data and incorporates information about genomic rearrangements, transcript orientation, and supporting reads. FusionCatcher identifies fusion genes using multiple alignment and filtering strategies. FusionInspector supports the examination and validation of candidate fusion events, while JAFFA provides a framework for identifying fusion transcripts using transcriptome assembly and alignment approaches. The selection of a tool depends on the sequencing technology, read length, library preparation, reference genome, and research objectives.
  • Fusion detection algorithms identify candidate events by examining unusual relationships between mapped sequencing reads. In a normal transcript, reads generally map to exons belonging to the same gene in an expected order and orientation. In a fusion transcript, one part of a read may map to one gene while another part maps to a different gene. Similarly, paired-end reads may map to two separate genes when their sequences originate from the same fusion molecule. These unusual alignments are examined to identify potential fusion partners and determine the approximate breakpoint positions.
  • Fusion transcript detection is closely associated with structural variant analysis, but the two approaches provide different types of information. Structural variant analysis generally investigates changes in genomic DNA, including translocations, inversions, deletions, and duplications. Fusion transcript analysis investigates RNA molecules that contain sequences from different genes. A genomic rearrangement may not produce a detectable fusion transcript if the affected genes are not expressed in the analyzed tissue. Conversely, a fusion transcript may occur through read-through transcription or other RNA-level mechanisms without a corresponding genomic rearrangement. Combining RNA sequencing with whole-genome sequencing (WGS), whole-exome sequencing (WES), or targeted DNA sequencing can help determine the underlying genomic mechanism.
  • The identification of fusion transcripts requires careful filtering because several technical and biological factors can generate false-positive results. Mapping errors may occur in repetitive regions, paralogous genes, pseudogenes, and highly similar genomic sequences. Read-through transcription between neighboring genes can be mistaken for a genomic fusion. Reverse transcriptase template switching and PCR amplification artifacts may also produce artificial chimeric sequences. Low-complexity sequences, poor-quality reads, and insufficient sequencing depth can further complicate detection. Reliable fusion identification therefore requires multiple supporting reads, consistent breakpoint evidence, appropriate mapping quality, and careful evaluation of genomic context.
  • Fusion transcript abundance can be estimated by counting the number of sequencing reads supporting a fusion event. A simplified measurement is:
    • Fusion Read Support = Split Reads + Supporting Spanning Read Pairs
  • Here, split reads directly cross the fusion breakpoint, while supporting spanning read pairs provide indirect evidence that the two fusion partners occur within the same RNA molecule. This is a simplified measure of supporting evidence rather than a standardized expression value. Different software packages use different definitions, filtering rules, and normalization methods. Fusion read support should therefore not be compared directly between studies without considering sequencing depth, library preparation, and the software used.
  • Fusion transcript detection is especially important in cancer research. Several cancers are associated with characteristic gene fusions that contribute to tumor development and progression. A well-known example is the BCR::ABL1 fusion, which results from a chromosomal rearrangement involving the BCR and ABL1 genes and produces an abnormal tyrosine kinase associated with chronic myeloid leukemia. Other examples include EML4::ALK fusions in a subset of lung cancers and TMPRSS2::ERG fusions in prostate cancer. These fusion events can alter cell signaling, proliferation, differentiation, and survival. Some are used as diagnostic biomarkers or therapeutic targets, although their clinical relevance depends on the specific cancer type and molecular context.
  • Fusion transcripts may also be investigated in non-cancer conditions and developmental biology. Certain gene fusions can influence normal cellular processes, while abnormal fusion events may contribute to inherited or acquired disorders. Research into fusion transcripts can reveal changes in gene regulation, protein structure, and molecular interactions. However, the detection of a fusion transcript alone does not establish that it causes a disease or produces a functional fusion protein.
  • Long-read sequencing technologies, including Oxford Nanopore and PacBio sequencing, provide additional opportunities for fusion transcript detection. Short-read RNA-seq may identify fusion breakpoints through split reads and discordant read pairs, but it can be difficult to reconstruct the complete fusion transcript when multiple exons are involved. Long reads can span larger portions of a fusion molecule, helping researchers identify the fusion partners, exon composition, breakpoint structure, and potential coding sequence. Tools such as FLAIR, minimap2-based workflows, and other long-read transcript analysis pipelines can support the identification and characterization of chimeric transcripts. Combining long-read and short-read data can improve both transcript structure characterization and supporting read evidence.
  • Fusion transcript detection also involves determining whether a predicted fusion can produce a functional protein. The coding sequence is examined to establish whether the fusion maintains an open reading frame or introduces a frameshift or premature stop codon. Protein domains, signal peptides, transmembrane regions, and localization signals can then be examined using resources such as UniProt and InterPro. Functional annotation may also involve Gene Ontology (GO), KEGG, Reactome, and protein-interaction databases such as STRING. These analyses can help predict the possible biological effects of a fusion transcript, although computational predictions require experimental confirmation.
  • In animal genomics and breeding research, fusion transcript detection can help investigate genome organization, transcriptional regulation, and unusual RNA processing events in livestock and other animal species. RNA-seq studies may identify candidate fusion transcripts associated with development, immune responses, reproductive biology, or disease conditions. Long-read sequencing can further characterize transcript structures and distinguish genuine fusion events from mapping artifacts or read-through transcription. Although fusion transcripts are not generally used as routine selection markers in animal breeding, their identification may contribute to functional genomics, disease research, and the characterization of complex transcriptomes.
  • Experimental validation is essential for confirming important fusion transcript candidates. Reverse transcription PCR (RT-PCR) can use primers positioned on opposite sides of the predicted fusion junction to amplify the fusion-specific sequence. Sanger sequencing of the amplified product can confirm the exact junction and the order of the fusion partners. Quantitative PCR (qPCR) can measure relative fusion transcript expression, while long-read sequencing can provide additional evidence of the complete transcript structure. Fluorescence in situ hybridization (FISH), genomic PCR, and targeted DNA sequencing may help establish whether a corresponding chromosomal rearrangement exists. Protein-level validation can be performed using Western blotting, immunohistochemistry, or other suitable methods when a fusion protein is predicted.
  • Several limitations must be considered when interpreting fusion transcript detection results. Fusion transcripts may be expressed at low levels or only in specific tissues and cell populations. Incomplete reference genomes and inaccurate gene annotations can affect breakpoint identification. Different sequencing protocols may produce different detection sensitivities, while computational algorithms may report different candidate sets from the same dataset. Read-through transcription, mapping ambiguity, and sequencing artifacts can also generate false positives. Consequently, fusion candidates should be evaluated using independent evidence, appropriate controls, and experimental validation.
  • Overall, fusion transcript detection is an important bioinformatics approach for identifying RNA molecules that combine sequences from different genes. RNA-seq, fusion-aware alignment, split-read analysis, spanning-read evidence, transcript assembly, and long-read sequencing enable researchers to discover and characterize fusion transcripts. Computational tools such as STAR-Fusion, Arriba, FusionCatcher, FusionInspector, and JAFFA support the detection and interpretation of candidate events. Combining transcriptomic evidence with genomic analysis and experimental validation improves confidence in fusion identification. Fusion transcript detection is therefore particularly valuable in cancer genomics, molecular diagnostics, functional genomics, and transcriptome research.
Author:

Leave a Reply

Your email address will not be published. Required fields are marked *